NS

Nadadur Sampath Vencatesan

Active Director Director DIN 09709274
DIN 09709274 First appointment Aug 2022 Primary industry Trading
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Nadadur Sampath Vencatesan

Data last updated:

Nadadur Sampath Vencatesan is a Director at Nrx Therapeutics Private Limited (since 2022). The company operates in Trading.

DIN 09709274
Primary Designation Director
Industry Trading
First Appointment 20 Aug 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Nrx Therapeutics Private Limited U51909TN2022PTC154712
Director20 Aug 20222022Active

Board colleagues of Nadadur Sampath Vencatesan

NameDINCompanyDesignation
Vishal Durai09709273Nrx Therapeutics Private LimitedDirector

Directorship timeline

Open interactive timeline →
Nrx Therapeutics Private Limited
Premium access

Shareholding and investment profile for Nadadur Sampath Vencatesan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nadadur Sampath Vencatesan

Nadadur Sampath Vencatesan currently holds 1 directorship: Nrx Therapeutics Private Limited (Director, since 20 Aug 2022).

Nadadur Sampath Vencatesan was first appointed on 20 Aug 2022 as Director at Nrx Therapeutics Private Limited.

The current boards of Nadadur Sampath Vencatesan's companies include Vishal Durai (Nrx Therapeutics Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available